Research progress on the activation mechanism of NLRP3 inflammasome in septic cardiomyopathy

被引:3
|
作者
Wen, Yuqi [1 ]
Liu, Yang [2 ]
Liu, Weihong [2 ]
Liu, Wenli [1 ]
Dong, Jinyan [1 ]
Liu, Qingkuo [1 ]
Hao, Hao [2 ]
Ren, Hongsheng [3 ]
机构
[1] Shandong Univ Tradit Chinese Med, Jinan, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250014, Peoples R China
[3] Shandong First Med Univ, Shandong Prov Hosp, Dept Intens Care Unit, Jinan 250014, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
activation mechanism; cytokines; inflammatory response; nucleotide-binding oligomerized structural domain-like receptor protein 3 inflammasome; septic cardiomyopathy; REGULATORY T-CELLS; SODIUM-INDUCED COLITIS; ULCERATIVE-COLITIS; BOWEL-DISEASE; GUT MICROBIOTA; LACTOBACILLUS-ACIDOPHILUS; INTESTINAL MACROPHAGES; PROBIOTIC VSLNUMBER-3; IMMUNE-RESPONSES; IL-23/IL-17; AXIS;
D O I
10.1002/iid3.1039
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is an uncontrolled host response to infection, resulting in a clinical syndrome involving multiple organ dysfunctions. Cardiac damage is the most common organ damage in sepsis. Uncontrolled inflammatory response is an important mechanism in the pathogenesis of septic cardiomyopathy (SCM). NLRP3 inflammasome promotes inflammatory response by controlling the activation of caspase-1 and the release of pro-inflammatory cytokines interleukin IL-1 beta and IL-18. The role of NLRP3 inflammasome has received increasing attention, but its activation mechanism and regulation of inflammation in SCM remain to be investigated. Inflammasomes play a key role in the development and progression of innate immunity and immunoinflammatory diseases. It was found that NLPR3 inflammasomes are closely related to sepsis and septic cardiomyopathy (SCM) and can be involved in regulating SCM through cardiomyocyte inflammatory response and apoptosis, oxidative stress injury, calcium regulation, endoplasmic reticulum stress, mitochondrial dysfunction, and exosomes.image
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
    Zhang, Tan
    Ding, Shuzhe
    Wang, Ru
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [2] Mechanism of NLRP3 inflammasome activation
    Sutterwala, Fayyaz S.
    Haasken, Stefanie
    Cassel, Suzanne L.
    YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION, 2014, 1319 : 82 - 95
  • [3] Molecular Mechanism of NLRP3 Inflammasome Activation
    Jin, Chengcheng
    Flavell, Richard A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (05) : 628 - 631
  • [4] Molecular Mechanism of NLRP3 Inflammasome Activation
    Chengcheng Jin
    Richard A. Flavell
    Journal of Clinical Immunology, 2010, 30 : 628 - 631
  • [5] Mechanism and Regulation of NLRP3 Inflammasome Activation
    He, Yuan
    Hara, Hideki
    Nunez, Gabriel
    TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (12) : 1012 - 1021
  • [6] A novel mechanism for NLRP3 inflammasome activation
    Zhang, Tan
    Zhao, Jingyao
    Liu, Tiemin
    Cheng, Wei
    Wang, Yibing
    Ding, Shuzhe
    Wang, Ru
    METABOLISM OPEN, 2022, 13
  • [7] Study on Esmolol Treating Septic Cardiomyopathy by Regulating NLRP3 Inflammasome
    Li, Yongxia
    Jiang, Jiamei
    Zhu, Xiaoguang
    Huang, Jiatiin
    Peng, Qiming
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2022, 22 (02) : 99 - 106
  • [8] NLRP3 inflammasome mechanism and therapeutic targets in diabetic cardiomyopathy
    Sun, Qing
    Guo, Wenxiu
    Yue, Tun
    Wang, Lu
    Mou, Huaming
    GACETA MEDICA DE MEXICO, 2023, 159 (03): : 261 - 267
  • [9] The NLRP3 Inflammasome and Diabetic Cardiomyopathy
    Singh, Lalit P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (01) : 5 - 6
  • [10] Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
    Zhang, Gu-Lao
    Liu, Yuan
    Liu, Yan-Feng
    Huang, Xian-Tao
    Tao, Yu
    Chen, Zhen-Huan
    Lai, Heng-Li
    WORLD JOURNAL OF DIABETES, 2024, 15 (04)